Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureArgelinda Baroni, F Xavier Castellanos
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Psychostimulants and cognition: a continuum of behavioral and cognitive activation
10.1124/pr.112.007054 · 2014
Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis
10.1007/s00787-009-0054-3 · 2010
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
2014
Clinical practice: adult attention deficit-hyperactivity disorder
10.1056/nejmcp1212625 · 2013
Misuse of stimulant medication among college students: a comprehensive review and meta-analysis
10.1007/s10567-014-0177-z · 2015
Trends in office-based treatment of adults with stimulants in the United States
10.4088/jcp.12m07975 · 2013
Does long-term medication use improve the academic outcomes of youth with attention-deficit/hyperactivity disorder?
10.1007/s10567-012-0117-8 · 2012
Are prescription stimulants “smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals
10.1037/a0023825 · 2011
Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers
10.3389/fnins.2013.00082 · 2013
Cognitive enhancement by drugs in health and disease
10.1016/j.tics.2010.11.002 · 2011
Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people
10.1016/s2215-0366(15)00004-8 · 2015
The cognitive atlas: toward a knowledge foundation for cognitive neuroscience
10.3389/fninf.2011.00017 · 2011
Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study
10.1001/jamapsychiatry.2013.4174 · 2014
Medication for attention deficit-hyperactivity disorder and criminality
10.1056/nejmoa1203241 · 2012
Enhancement stimulants: perceived motivational and cognitive advantages
10.3389/fnins.2013.00198 · 2013
Treatment of children with attention-deficit/hyperactivity disorder (ADHD) and irritability: results from the multimodal treatment study of children with ADHD (MTA)
10.1016/j.jaac.2014.10.006 · 2015
Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway
10.1038/mp.2010.97 · 2011
What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD)
10.1016/j.neubiorev.2010.03.006 · 2010
Prescription stimulants’ effects on healthy inhibitory control, working memory, and episodic memory: a meta-analysis
2015
The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder
10.1016/j.biopsych.2006.12.030 · 2007
Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies
10.1017/s1461145713001594 · 2014
The MATRICS consensus cognitive battery: what we know 6 years later
10.1176/appi.ajp.2014.14070936 · 2014
Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis
10.1016/j.biopsych.2013.10.005 · 2014
Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate
10.1089/cap.2014.0015 · 2015
Reaction time variability in ADHD: a meta-analytic review of 319 studies
10.1016/j.cpr.2013.06.001 · 2013
Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability
10.1016/j.biopsych.2010.11.014 · 2011
Cognitive enhancers for the treatment of ADHD
10.1016/j.pbb.2011.05.002 · 2011
Long-term effects of stimulants on neurocognitive performance of Taiwanese children with attention-deficit/hyperactivity disorder
10.1186/1471-244x-13-330 · 2013
Effects of methylphenidate on intelligence and attention components in boys with attention-deficit/hyperactivity disorder
10.1089/cap.2010.0041 · 2011
OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study
10.1016/j.euroneuro.2014.01.007 · 2014
How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis
10.1007/s00787-012-0346-x · 2013
College students with and without ADHD: comparison of self-report of medication usage, study habits, and academic achievement
10.1177/1087054710371168 · 2011
Do stimulants improve functioning in adults with ADHD? A review of the literature
10.1016/j.euroneuro.2012.02.010 · 2013
Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD
10.1017/s1461145711001131 · 2012
Four-year outcome in psychopharmacologically treated adults with attention-deficit/hyperactivity disorder: a questionnaire survey
10.4088/jcp.12m07714 · 2013
Stimulant ADHD medication and risk for substance abuse
10.1111/jcpp.12164 · 2014
Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder
10.1192/bjp.bp.112.124784 · 2013
Stimulant medication and substance use outcomes: a meta-analysis
10.1001/jamapsychiatry.2013.1273 · 2013
Stimulants improve theory of mind in children with attention deficit/hyperactivity disorder
10.1177/0269881113492030 · 2014
Modulation of social influence by methylphenidate
10.1038/npp.2011.337 · 2012
Enhancement of human cognitive performance using transcranial magnetic stimulation (TMS)
10.1016/j.neuroimage.2013.06.007 · doi-reference
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data
10.1007/s11682-013-9269-5 · doi-reference
Multilevel models from biology to psychology: mission impossible?
10.1037/a0032263 · doi-reference
Executive impairment determines ADHD medication response: implications for academic achievement
10.1177/0022219410391191 · doi-reference
Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior
10.1126/science.337493 · doi-reference
“Paradoxical" effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology
10.1016/0028-3908(79)90157-6 · doi-reference
Are the effects of psychomotor stimulant drugs on hyperactive children really paradoxical?
10.1016/0306-9877(77)90065-2 · doi-reference
A person-centered investigation of academic motivation and its correlates in high school
10.1016/j.lindif.2012.03.004 · doi-reference
Effort, anhedonia, and function in schizophrenia: reduced effort allocation predicts amotivation and functional impairment
10.1037/a0036299 · doi-reference
The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology
10.1002/wps.20087 · doi-reference
The association between sluggish cognitive tempo and academic functioning in youth with attention-deficit/hyperactivity disorder (ADHD)
10.1007/s10802-013-9722-3 · doi-reference
Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers
10.1016/j.neuropharm.2012.07.009 · doi-reference
Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain
10.1176/appi.ajp.161.7.1173 · doi-reference
Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people
10.1016/j.neuropharm.2012.07.021 · doi-reference
Social cognition in attention-deficit hyperactivity disorder (ADHD)
10.1016/j.neubiorev.2009.10.009 · doi-reference
The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial
10.1177/1087054712448252 · doi-reference
Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD
10.3109/15622971003624197 · doi-reference
Using stimulants to treat ADHD-related emotional lability
10.1007/s11920-014-0478-4 · doi-reference
Multiple deficits in ADHD: executive dysfunction, delay aversion, reaction time variability, and emotional deficits
10.1111/jcpp.12006 · doi-reference
Is emotional dysregulation part of the psychopathology of ADHD in adults?
10.1007/s12402-012-0097-z · doi-reference
The Affective Reactivity Index: a concise irritability scale for clinical and research settings
10.1111/j.1469-7610.2012.02561.x · doi-reference
Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence
10.1111/j.1469-7610.2010.02217.x · doi-reference
Everyday emotional experience of adults with attention deficit hyperactivity disorder: evidence for reactive and endogenous emotional lability
10.1017/s0033291714001032 · doi-reference
The use of stimulant medications for non-core aspects of ADHD and in other disorders
10.1016/j.neuropharm.2014.06.014 · doi-reference
Just how cognitive is “cognitive enhancement"? On the significance of emotions in university students’ experiences with study drugs
10.1080/21507740.2012.740141 · doi-reference